Abstract

Betahistine 16-mg Capsules

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2013 - Volume 17, Number 2

Page(s): 146

Download in electronic PDF format for $75
  • Betahistine 16-mg Capsules Page 1

Abstract

A formulation for preparing Betahistine 16-mg Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • betahistine
  • antivertigo agent
  • vertigo
  • balance disorders
  • vasodilator
  • Meniere disease
  • histamine H1 receptor agonist
  • histamine H3 receptor antagonist

Related Categories

  • EAR NOSE THROAT
  • FORMULATIONS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2013
Pg. 146
Betahistine 16-mg Capsules
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2000
Pg. 26-27
Book Review: The NMDA Receptor
Author(s): Jones Marty
Mar/Apr 2003
Pg. 120-123
Technology Spotlight: Electronic Balances with Printer and Draft Shield
Author(s): Wesolowski Paul
Sep/Oct 2005
Pg. 339-346
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain
Author(s): Mishkan Emilyn S
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Mar/Apr 2016
Pg. 147
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Author(s): Allen Loyd V Jr
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
May/Jun 2023
Pg. 192-200
Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development
Author(s): Riepl Mike, Kaiser Joe
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jan/Feb 2018
Pg. 76-85
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection
Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018
Pg. 86-94
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Jul/Aug 2011
Pg. 302-307
Treating Inner Ear Disorders with Intratympanic Drug Administration
Author(s): McElhiney Linda F
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Jan/Feb 2016
Pg. 48
Aprepitant 80-mg Capsules
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 237
Valsartan 16-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2006
Pg. 382
Famotidine 8-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 1999
Pg. 280-283
Antique Pharmaceutical Balances
Author(s): Richardson Charles G